Table 3.

Association of day 100 CCL15 levels with subsequent cGVHD (n = 792)

Prognostic marker	Area ROC	P
CCL15	0.56	.03
Clinical factors*	0.61	.10†
CCL15 + steroid use + female to male sex	0.62	.001

^*Female to male sex, donor relation/match, stem cell source, age, conditioning, steroid use.

^†Only steroid use (P = .02) and female to male sex (P = .04) are statistically significant.